The Study of Clinical Efficacy and Safety of Benjakul Remedy in Stage 4 Non Small Cell Lung Cancer
- Conditions
- Diagnosed with non-small cell lung cancer stage 4,confirmed by pathology and radiology and do not respond to chemotherapy at least two formulas and can not be treated with drugs targettedCarcinoma,Non-Small-Cell Lung [C04.588.894.797.520.109.220.249]
- Registration Number
- TCTR20150805001
- Lead Sponsor
- ational research council of thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
1. Females and males aged 25-70 years
2. Diagnosed with non-small cell lung cancer stage 4, confirmed by pathology and radiology
3. Do not respond to chemotherapy at least two formulas and can not be treated with drugs targetted.
4. Have never used herbs in the treatment of non-small cell lung cancer.
5. ECOG (Eastern Cooperative Oncology Group) performance status performance patients based on a scale of 0 to 2A
6. The following laboratory criteria
6.1 Hemoglobin ≥ 10 grams per deciliter
6.2 Leukocytes ≥ 3.0 x 109 / L
6.3 Lymphocyte Type of neutrophils >Â 1.5 x 109 / L
6.4 Platelet >Â 75 x 109 / L
6.5 Aspartate transferase (AST), alanine aminotransferase (ALT), alkaline phosphatase(ALP), bilirubin no more than 3 times that of standard
6.6 Creatinine no more than 1.5 mg per deciliter
7. Patients treated and followed up on schedule.
8. Volunteers must make a conscious decision to participate in the research themselves.
9. Patient understands and signs consent to participate in research.
1. ECOG Performance status in range the 3 to 5
2. The disease has spread to the brain
3. Has herbal drug allergy
4. Are pregnant or breastfeeding
5. Taking chemotherapy or other herbs during the study
6. Take medicine regularly for peptic ulcer
7. People who have problems swallowing who can not eat the capsule
8. Are participating in other research programs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method